Production (Stage)
Vigil Neuroscience, Inc.
VIGL
$7.89
$0.010.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.96M | 6.45M | 6.90M | 6.94M | 7.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.47M | 25.11M | 20.68M | 22.48M | 21.42M |
| Operating Income | -23.47M | -25.11M | -20.68M | -22.48M | -21.42M |
| Income Before Tax | -22.41M | -23.83M | -19.26M | -21.23M | -19.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.41M | -23.83M | -19.26M | -21.23M | -19.94M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.41M | -23.83M | -19.26M | -21.23M | -19.94M |
| EBIT | -23.47M | -25.11M | -20.68M | -22.48M | -21.42M |
| EBITDA | -23.35M | -25.00M | -20.56M | -22.37M | -21.30M |
| EPS Basic | -0.49 | -0.57 | -0.47 | -0.52 | -0.50 |
| Normalized Basic EPS | -0.30 | -0.36 | -0.30 | -0.33 | -0.31 |
| EPS Diluted | -0.49 | -0.57 | -0.47 | -0.52 | -0.50 |
| Normalized Diluted EPS | -0.30 | -0.36 | -0.30 | -0.33 | -0.31 |
| Average Basic Shares Outstanding | 46.07M | 41.66M | 40.58M | 40.56M | 39.86M |
| Average Diluted Shares Outstanding | 46.07M | 41.66M | 40.58M | 40.56M | 39.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |